Cohort Studyhigh evidence
Genetic predictors of GLP1 receptor agonist weight loss and side effects.
Nature·April 8, 2026·PMID 41951734
Why it mattersIt provides direct genetic evidence that variation in drug target genes contributes to inter-individual variability in GLP1 agonist response, laying groundwork for precision medicine in obesity treatment.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled